Where Strategy Meets Storytelling

Published

July 26, 2025

Author

Leena Vayalil

Leena Vayalil is a neuroscience intelligence analyst focused on major depressive disorder (MDD), treatment-resistant depression (TRD), and MDD with insomnia. She transforms complexity into strategic insight for mental health brands.

Behind every successful launch is a story—one that connects science to value, evidence to urgency, and innovation to impact. At IAMAI, we help you craft that story with strategic clarity and creative precision.

We sit at the intersection of medical communication and commercial execution—where clinical strategy becomes actionable narrative. Our work supports pharmaceutical and biotech teams at every stage of the product lifecycle, especially when stakes are high and the path forward is complex.

We’ve helped teams:

  • Launch novel therapies with differentiated scientific positioning
  • Accelerate internal readiness across medical, access, and field teams
  • Navigate reimbursement and coverage challenges with messaging that aligns clinical value to operational realities

We don’t just build decks—we build narratives. Narratives that hold up to medical scrutiny, align with brand strategy, and equip your teams to educate with confidence. Whether you're communicating MOA to clinicians, aligning leadership on value messaging, or developing pull-through resources for account teams—we make the message matter.

Our team of strategists, writers, and educators understands the nuance required to communicate complex science in a way that’s not only clear, but compelling. We combine scientific rigor with the art of storytelling, ensuring every asset—from a single slide to an entire campaign—delivers clarity, credibility, and cohesion.

If you’re preparing for an approval, entering a new therapeutic space, or building alignment across your teams, IAMAI can help you translate strategy into stories that move people—and markets.

Let’s advance your next project together.